{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T13:37:01Z","timestamp":1794490621277,"version":"4.9.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T00:00:00Z","timestamp":1668729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T00:00:00Z","timestamp":1668729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1245\/s10434-022-12698-4","type":"journal-article","created":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T19:04:15Z","timestamp":1668798255000},"page":"2497-2505","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Safety and Feasibility of High-Pressure\/High-Dose Pressurized Intraperitoneal Aerosol Chemotherapy (HP\/HD-PIPAC) for Primary and Metastatic Peritoneal Surface Malignancies"],"prefix":"10.1245","volume":"30","author":[{"given":"Gabriel","family":"Ramos Arias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9my","family":"Sindayigaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Ouaissi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan R.","family":"Buggisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Schmeding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urs","family":"Giger-Pabst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Zieren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,18]]},"reference":[{"issue":"7","key":"12698_CR1","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1093\/jnci\/89.7.480","volume":"89","author":"RL Dedrick","year":"1997","unstructured":"Dedrick RL, Flessner MF. Pharmacokinetic problems in peritoneal drug administration: tissue penetration and surface exposure. Journal of the National Cancer Institute. 1997;89(7):480\u20137. https:\/\/doi.org\/10.1093\/jnci\/89.7.480.","journal-title":"Journal of the National Cancer Institute"},{"issue":"7","key":"12698_CR2","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1007\/s00464-012-2148-0","volume":"26","author":"W Sola\u00df","year":"2012","unstructured":"Sola\u00df W, Hetzel A, Nadiradze G, Sagynaliev E, Reymond MA. Description of a novel approach for intraperitoneal drug delivery and the related device. Surg Endosc. 2012;26(7):1849\u201355. https:\/\/doi.org\/10.1007\/s00464-012-2148-0.","journal-title":"Surg Endosc."},{"issue":"2","key":"12698_CR3","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1245\/s10434-013-3213-1","volume":"21","author":"W Solass","year":"2014","unstructured":"Solass W, Kerb R, M\u00fcrdter T, Giger-Pabst U, Strumberg D, Tempfer C, et al. Intraperitoneal chemotherapy of peritoneal carcinomatosis using pressurized aerosol as an alternative to liquid solution: first evidence for efficacy. Ann Surg Oncol. 2014;21(2):553\u20139. https:\/\/doi.org\/10.1245\/s10434-013-3213-1.","journal-title":"Ann Surg Oncol."},{"issue":"4","key":"12698_CR4","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/codi.13130","volume":"18","author":"C Demtr\u00f6der","year":"2016","unstructured":"Demtr\u00f6der C, Solass W, Zieren J, et al. Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin in colorectal peritoneal metastasis. Colorectal Dis. 2016;18(4):364\u201371.","journal-title":"Colorectal Dis."},{"key":"12698_CR5","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s11605-015-2995-9","volume":"20","author":"G Nadiradze","year":"2016","unstructured":"Nadiradze G, Giger-Pabst U, Zieren J, Strumberg D, Solass W, Reymond M-A. Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) with Low-Dose Cisplatin and Doxorubicin in Gastric Peritoneal Metastasis. J Gastrointest Surg. 2016;20:367\u201373.","journal-title":"J Gastrointest Surg."},{"key":"12698_CR6","doi-asserted-by":"publisher","first-page":"e368","DOI":"10.1016\/S1470-2045(19)30318-3","volume":"20","author":"M Alyami","year":"2019","unstructured":"Alyami M, H\u00fcbner M, Grass F, Bakrin N, Villeneuve L, Laplace N, et al. Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indications. The Lancet Oncology. 2019;20:e368\u201377.","journal-title":"The Lancet Oncology."},{"issue":"1","key":"12698_CR7","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1245\/s10434-021-10860-y","volume":"29","author":"R Sindayigaya","year":"2022","unstructured":"Sindayigaya R, Dogan C, Demtr\u00f6der CR, et al. Clinical outcome for patients managed with low-dose cisplatin and doxorubicin delivered as pressurized intraperitoneal aerosol chemotherapy for unresectable peritoneal metastases of gastric cancer. Annals of Surgical Oncology. 2022;29(1):112\u201323. https:\/\/doi.org\/10.1245\/s10434-021-10860-y.","journal-title":"Annals of Surgical Oncology."},{"issue":"7","key":"12698_CR8","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1158\/1078-0432.CCR-20-2152","volume":"27","author":"G Kim","year":"2021","unstructured":"Kim G, Tan HL, Sundar R, Lieske B, Chee CE, Ho J, et al. PIPAC-OX: a phase I study of oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy in patients with peritoneal metastases. Clin Cancer Res. 2021;27(7):1875\u201381. https:\/\/doi.org\/10.1158\/1078-0432.CCR-20-2152.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"12698_CR9","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.3390\/cancers13051060","volume":"13","author":"M Robella","year":"2021","unstructured":"Robella M, De Simone M, Berchialla P, Argenziano M, Borsano A, Ansari S, et al. A phase I dose escalation study of oxaliplatin, cisplatin and doxorubicin applied as PIPAC in patients with peritoneal carcinomatosis. Cancers (Basel). 2021;13(5):1060. https:\/\/doi.org\/10.3390\/cancers13051060.","journal-title":"Cancers (Basel)."},{"issue":"1","key":"12698_CR10","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12957-017-1109-4","volume":"15","author":"V Khosrawipour","year":"2017","unstructured":"Khosrawipour V, Diaz-Carballo D, Acikelli AH, Khosrawipour T, Falkenstein TA, Wu D, et al. Cytotoxic effect of different treatment parameters in pressurized intraperitoneal aerosol chemotherapy (PIPAC) on the in vitro proliferation of human colonic cancer cells. World J Surg Oncol. 2017;15(1):43.","journal-title":"World J Surg Oncol."},{"key":"12698_CR11","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1186\/s12885-021-07955-w","volume":"21","author":"M Mimouni","year":"2021","unstructured":"Mimouni M, Richard C, Adenot P, et al. Pressurized intra-peritoneal aerosol chemotherapy (PIPAC): increased intraperitoneal pressure does not affect distribution patterns but leads to deeper penetration depth of doxorubicin in a sheep model. BMC Cancer. 2021;21:461. https:\/\/doi.org\/10.1186\/s12885-021-07955-w.","journal-title":"BMC Cancer."},{"issue":"6","key":"12698_CR12","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","volume":"5","author":"MM Oken","year":"1982","unstructured":"Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5(6):649\u201355.","journal-title":"Am J Clin Oncol."},{"key":"12698_CR13","unstructured":"Karnofsky, DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In: CM MacLeod (Hrsg.). Evaluation of chemotherapeutic agents. Columbia University Press; 1949. S.196"},{"issue":"12","key":"12698_CR14","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1007\/s11605-018-3916-5","volume":"22","author":"U Giger-Pabst","year":"2018","unstructured":"Giger-Pabst U, Tempfer CB. How to perform safe and technically optimized pressurized intraperitoneal aerosol chemotherapy (PIPAC): experience after a consecutive series of 1200 procedures. Journal of Gastrointestinal Surgery. 2018;22(12):2187\u201393.","journal-title":"Journal of Gastrointestinal Surgery."},{"issue":"5","key":"12698_CR15","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1200\/JCO.2008.19.7160","volume":"27","author":"D Elias","year":"2009","unstructured":"Elias D, Lefevre JH, Chevalier J, Brouquet A, Marchal F, Classe J-M, Ferron G, et al. Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J Clinical Oncology. 2009;27(5):681\u20135. https:\/\/doi.org\/10.1200\/JCO.2008.19.7160.","journal-title":"J. Clinical Oncology"},{"issue":"4","key":"12698_CR16","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/codi.13130","volume":"18","author":"C Demtr\u00f6der","year":"2016","unstructured":"Demtr\u00f6der C, Solass W, Zieren J, Strumberg D, Giger-Pabst U. M-A Reymond Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin in colorectal peritoneal metastasis. Colorectal Dis. 2016;18(4):364\u201371. https:\/\/doi.org\/10.1111\/codi.13130.","journal-title":"Colorectal Dis."},{"issue":"2","key":"12698_CR17","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","volume":"250","author":"PA Clavien","year":"2009","unstructured":"Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al. The Clavien\u2013Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250(2):187\u201396. https:\/\/doi.org\/10.1097\/SLA.0b013e3181b13ca2 (PMID: 19638912).","journal-title":"Ann Surg."},{"issue":"5","key":"12698_CR18","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1080\/02656736.2017.1291999","volume":"33","author":"L Lemoine","year":"2017","unstructured":"Lemoine L, Sugarbaker P, Van der Speeten K. Drugs, doses, and durations of intraperitoneal chemotherapy: standardising HIPEC and EPIC for colorectal, appendiceal, gastric, ovarian peritoneal surface malignancies and peritoneal mesothelioma. Int J Hyperthermia. 2017;33(5):582\u201392. https:\/\/doi.org\/10.1080\/02656736.2017.1291999.","journal-title":"Int J Hyperthermia."},{"issue":"1","key":"12698_CR19","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ygyno.2018.05.001","volume":"150","author":"CB Tempfer","year":"2018","unstructured":"Tempfer CB, Giger-Pabst U, Seebacher V, Petersen M, Dogan A, Rezniczek GA. A phase I, single-arm, open-label, dose escalation study of intraperitoneal cisplatin and doxorubicin in patients with recurrent ovarian cancer and peritoneal carcinomatosis. Gynecol Oncol. 2018;150(1):23\u201330. https:\/\/doi.org\/10.1016\/j.ygyno.2018.05.001.","journal-title":"Gynecol Oncol."},{"key":"12698_CR20","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s12957-016-0892-7","volume":"14","author":"M Robella","year":"2016","unstructured":"Robella M, Vaira M, De Simone M. Safety and feasibility of pressurized intraperitoneal aerosol chemotherapy (PIPAC) associated with systemic chemotherapy: an innovative approach to treat peritoneal carcinomatosis. World J Surg Oncol. 2016;14:128. https:\/\/doi.org\/10.1186\/s12957-016-0892-7.","journal-title":"World J Surg Oncol."},{"issue":"1","key":"12698_CR21","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12885-020-6572-6","volume":"20","author":"M Ploug","year":"2020","unstructured":"Ploug M, Graversen M, Pfeiffer P, Mortensen MB. Bidirectional treatment of peritoneal metastasis with Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) and systemic chemotherapy: a systematic review. BMC Cancer. 2020;20(1):105. https:\/\/doi.org\/10.1186\/s12885-020-6572-6.","journal-title":"BMC Cancer."},{"issue":"9","key":"12698_CR22","doi-asserted-by":"publisher","first-page":"5275","DOI":"10.1245\/s10434-020-09508-0","volume":"28","author":"N Tabchouri","year":"2021","unstructured":"Tabchouri N, Buggisch J, Demtr\u00f6der CR, Thiery J, Rezniczek G, Tempfer CB, et al. Pressurized intraperitoneal aerosol chemotherapy for colorectal peritoneal metastases. Ann Surg Oncol. 2021;28(9):5275\u201386. https:\/\/doi.org\/10.1245\/s10434-020-09508-0.","journal-title":"Ann Surg Oncol."},{"issue":"1","key":"12698_CR23","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1245\/s10434-021-10860-y","volume":"29","author":"R Sindayigaya","year":"2022","unstructured":"Sindayigaya R, Dogan C, Demtr\u00f6der CR, Fischer B, Karam E, Buggisch JR, et al. Clinical outcome for patients managed with low-dose cisplatin and doxorubicin delivered as pressurized intraperitoneal aerosol chemotherapy for unresectable peritoneal metastases of gastric cancer. Ann Surg Oncol. 2022;29(1):112\u201323. https:\/\/doi.org\/10.1245\/s10434-021-10860-y.","journal-title":"Ann Surg Oncol."},{"issue":"6","key":"12698_CR24","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.3390\/cancers14061443","volume":"14","author":"P Horvath","year":"2022","unstructured":"Horvath P, Yurttas C, Baur I, Steidle C, Reymond MA, Girotti PNC, et al. Current medical care situation of patients in Germany undergoing pressurized intraperitoneal aerosol chemotherapy (PIPAC). Cancers. 2022;14(6):1443. https:\/\/doi.org\/10.3390\/cancers14061443.","journal-title":"Cancers."},{"issue":"8","key":"12698_CR25","doi-asserted-by":"publisher","first-page":"5243","DOI":"10.1245\/s10434-022-11577-2","volume":"29","author":"A Taibi","year":"2022","unstructured":"Taibi A, Sgarbura O, H\u00fcbner M, Bardet SM, Alyami M, Bakrin N, et al. Feasibility and safety of oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy with or without intraoperative intravenous 5-fluorouracil and Leucovorin for colorectal peritoneal metastases: a multicenter comparative cohort study. Ann Surg Oncol. 2022;29(8):5243\u201351. https:\/\/doi.org\/10.1245\/s10434-022-11577-2.","journal-title":"Ann Surg Oncol."},{"issue":"5","key":"12698_CR26","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.3892\/ijmm.2013.1496","volume":"32","author":"T Yu","year":"2013","unstructured":"Yu T, Liu K, Wu Y, Fan J, Chen J, Li C, et al. High interstitial fluid pressure promotes tumor cell proliferation and invasion in oral squamous cell carcinoma. Int J Mol Med. 2013;32(5):1093\u2013100. https:\/\/doi.org\/10.3892\/ijmm.2013.1496.","journal-title":"Int J Mol Med."},{"issue":"7","key":"12698_CR27","first-page":"1993","volume":"52","author":"R Gutmann","year":"1992","unstructured":"Gutmann R, Leunig M, Feyh J, Goetz AE, Messmer K, Kastenbauer E, Jain RK. Interstitial hypertension in head and neck tumors in patients: correlation with tumor size. Cancer Res. 1992;52(7):1993\u20135.","journal-title":"Cancer Res."},{"issue":"4","key":"12698_CR28","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1002\/jcb.21187","volume":"101","author":"D Fukumura","year":"2007","unstructured":"Fukumura D, Jain RK. Tumor microenvironment abnormalities: causes, consequences, and strategies to normalize. J Cell Biochem. 2007;101(4):937\u201349. https:\/\/doi.org\/10.1002\/jcb.21187.","journal-title":"J Cell Biochem."},{"issue":"24","key":"12698_CR29","first-page":"6695","volume":"51","author":"HD Roh","year":"1991","unstructured":"Roh HD, Boucher Y, Kalnicki S, Buchsbaum R, Bloomer WD, Jain RK. Interstitial hypertension in carcinoma of uterine cervix in patients: possible correlation with tumor oxygenation and radiation response. Cancer Res. 1991;51(24):6695\u20138.","journal-title":"Cancer Res."},{"issue":"7","key":"12698_CR30","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.neo.2014.07.003","volume":"16","author":"EK Rofstad","year":"2014","unstructured":"Rofstad EK, Galappathi K, Mathiesen BS. Tumor interstitial fluid pressure\u2014a link between tumor hypoxia, microvascular density, and lymph node metastasis. Neoplasia. 2014;16(7):586\u201394. https:\/\/doi.org\/10.1016\/j.neo.2014.07.003.","journal-title":"Neoplasia."},{"issue":"17","key":"12698_CR31","first-page":"6400","volume":"61","author":"M Milosevic","year":"2001","unstructured":"Milosevic M, Fyles A, Hedley D, Pintilie M, Levin W, Manchul L, et al. Interstitial fluid pressure predicts survival in patients with cervix cancer independent of clinical prognostic factors and tumor oxygen measurements. Cancer Res. 2001;61(17):6400\u20135.","journal-title":"Cancer Res."},{"issue":"2","key":"12698_CR32","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.radonc.2006.07.014","volume":"80","author":"A Fyles","year":"2006","unstructured":"Fyles A, Milosevic M, Pintilie M, Syed A, Levin W, Manchul L, et al. Long-term performance of interstial fluid pressure and hypoxia as prognostic factors in cervix cancer. Radiother Oncol. 2006;80(2):132\u20137. https:\/\/doi.org\/10.1016\/j.radonc.2006.07.014.","journal-title":"Radiother Oncol."},{"key":"12698_CR33","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-2407-8-2","volume":"8","author":"SJ Lunt","year":"2008","unstructured":"Lunt SJ, Kalliomaki TM, Brown A, Yang VX, Milosevic M, Hill RP. Interstitial fluid pressure, vascularity and metastasis in ectopic, orthotopic and spontaneous tumours. BMC Cancer. 2008;8:2. https:\/\/doi.org\/10.1186\/1471-2407-8-2.","journal-title":"BMC Cancer."},{"issue":"10","key":"12698_CR34","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/nrc1456","volume":"4","author":"CH Heldin","year":"2004","unstructured":"Heldin CH, Rubin K, Pietras K, Ostman A. High interstitial fluid pressure\u2014an obstacle in cancer therapy. Nat Rev Cancer. 2004;4(10):806\u201313. https:\/\/doi.org\/10.1038\/nrc1456.","journal-title":"Nat Rev Cancer."},{"issue":"1","key":"12698_CR35","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3390\/cancers12010034","volume":"12","author":"G Nadiradze","year":"2020","unstructured":"Nadiradze G, Horvath P, Sautkin Y, Archid R, Weinreich F-J, K\u00f6nigsrainer A, et al. Overcoming drug resistance by taking advantage of physical principles: pressurized intraperitoneal aerosol chemotherapy (PIPAC). Cancers. 2020;12(1):34. https:\/\/doi.org\/10.3390\/cancers12010034.","journal-title":"Cancers."},{"issue":"1","key":"12698_CR36","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1097\/01.sla.0000218089.61635.5f","volume":"244","author":"P Esquis","year":"2006","unstructured":"Esquis P, Consolo D, Magnin G, Pointaire P, Moretto P, Ynsa MD, et al. High intra-abdominal pressure enhances the penetration and antitumor effect of intraperitoneal cisplatin on experimental peritoneal carcinomatosis. Ann Surg. 2006;244(1):106\u201312. https:\/\/doi.org\/10.1097\/01.sla.0000218089.61635.5f.","journal-title":"Ann Surg."},{"issue":"6","key":"12698_CR37","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1097\/SLA.0b013e3182582b38","volume":"256","author":"O Facy","year":"2012","unstructured":"Facy O, Al Samman S, Magnin G, Ghiringhelli F, Ladoire S, Chauffert B, et al. High pressure enhances the effect of hyperthermia in intraperitoneal chemotherapy with oxaliplatin: an experimental study. Ann Surg. 2012;256(6):1084\u20138. https:\/\/doi.org\/10.1097\/SLA.0b013e3182582b38.","journal-title":"Ann Surg."},{"issue":"5","key":"12698_CR38","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1097\/00001813-199607000-00016","volume":"7","author":"P Jacquet","year":"1996","unstructured":"Jacquet P, Stuart OA, Chang D, Sugarbaker PH. Effects of intra-abdominal pressure on pharmacokinetics and tissue distribution of doxorubicin after intraperitoneal administration. Anticancer Drugs. 1996;7(5):596\u2013603. https:\/\/doi.org\/10.1097\/00001813-199607000-00016.","journal-title":"Anticancer Drugs."},{"issue":"2","key":"12698_CR39","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.bjane.2013.03.020","volume":"64","author":"O Hypolito","year":"2014","unstructured":"Hypolito O, Azevedo JL, Gama F, Azevedo O, Miyahira SA, Pires OC, et al. Effects of elevated artificial pneumoperitoneum pressure on invasive blood pressure and levels of blood gases. Braz J Anesthesiol. 2014;64(2):98\u2013104. https:\/\/doi.org\/10.1016\/j.bjane.2013.03.020.","journal-title":"Braz J Anesthesiol."},{"issue":"2","key":"12698_CR40","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1089\/lap.1999.9.131","volume":"9","author":"JB Adams","year":"1999","unstructured":"Adams JB, Moore RG, Micali S, Marco AP, Kavoussi LR. Laparoscopic genitourinary surgery utilizing 20\u00a0mmHg intra-abdominal pressure. J Laparoendosc Adv Surg Tech A. 1999;9(2):131\u20134. https:\/\/doi.org\/10.1089\/lap.1999.9.131.","journal-title":"J Laparoendosc Adv Surg Tech A."},{"issue":"1","key":"12698_CR41","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ejso.2019.06.022","volume":"47","author":"S Kusamura","year":"2021","unstructured":"Kusamura S, Azmi N, Fumagalli L, Baratti D, Guaglio M, Cavalleri A, et al. Phase II randomized study on tissue distribution and pharmacokinetics of cisplatin according to different levels of intra-abdominal pressure (IAP) during HIPEC (NCT02949791). Eur J Surg Oncol. 2021;47(1):82\u20138. https:\/\/doi.org\/10.1016\/j.ejso.2019.06.022.","journal-title":"Eur J Surg Oncol."},{"issue":"10 Pt A","key":"12698_CR42","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1016\/j.ejso.2020.02.006","volume":"46","author":"ACV Reis","year":"2020","unstructured":"Reis ACV, Kusamura S, Azmi N, Fumagalli L, Piccioni F, Valenza F, et al. Hemodynamic and respiratory implications of high intra-abdominal pressure during HIPEC. Eur J Surg Oncol. 2020;46(10 Pt A):1896\u2013901. https:\/\/doi.org\/10.1016\/j.ejso.2020.02.006.","journal-title":"Eur J Surg Oncol."},{"issue":"3","key":"12698_CR43","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1245\/s10434-017-6279-3","volume":"25","author":"M Goldenshluger","year":"2018","unstructured":"Goldenshluger M, Zippel D, Ben-Yaacov A, Dux J, Yalon T, Zendel A, et al. Core body temperature but not intraabdominal pressure predicts postoperative complications following closed-system Hyperthermic Intraperitoneal Chemotherapy (HIPEC) administration. Ann Surg Oncol. 2018;25(3):660\u20136. https:\/\/doi.org\/10.1245\/s10434-017-6279-3.","journal-title":"Ann Surg Oncol."},{"issue":"4","key":"12698_CR44","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1007\/s00464-016-5174-5","volume":"31","author":"D G\u00f6hler","year":"2017","unstructured":"G\u00f6hler D, Khosrawipour V, Khosrawipour T, Diaz-Carballo D, Falkenstein TA, Zieren J, et al. Technical description of the microinjection pump (MIP\u00ae) and granulometric characterization of the aerosol applied for pressurized intraperitoneal aerosol chemotherapy (PIPAC). Surg Endosc. 2017;31(4):1778\u201384. https:\/\/doi.org\/10.1007\/s00464-016-5174-5.","journal-title":"Surg Endosc."},{"issue":"13","key":"12698_CR45","doi-asserted-by":"publisher","first-page":"4445","DOI":"10.1245\/s10434-019-07695-z","volume":"26","author":"U Giger-Pabst","year":"2019","unstructured":"Giger-Pabst U, Bucur P, Roger S, Falkenstein TA, Tabchouri N, Le Pape A, et al. Comparison of tissue and blood concentrations of oxaliplatin administrated by different modalities of intraperitoneal chemotherapy. Ann Surg Oncol. 2019;26(13):4445\u201351. https:\/\/doi.org\/10.1245\/s10434-019-07695-z.","journal-title":"Ann Surg Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-12698-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-022-12698-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-12698-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T10:03:59Z","timestamp":1679306639000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-022-12698-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,18]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["12698"],"URL":"https:\/\/doi.org\/10.1245\/s10434-022-12698-4","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,18]]},"assertion":[{"value":"21 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Gabriel Ramos Arias, R\u00e9my Sindayigaya, Mehdi Ouaissi, Jonathan R. Buggisch, Maximilian Schmeding, Urs Giger-Pabst, and J\u00fcrgen Zieren have no conflicts of interest or financial ties to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"DISCLOSURES"}}]}}